Sharescart Research Club logo
Apollo Green 56 (-3.4%)ASK Investment 925 (0%)CIAL 444 (1.4%)CSK 258 (-2.3%)ESDS Software 468 (4.5%)Garuda Aerospace 468 (-3.5%)India Carbon 895 (0%)Indian Potash 2850 (0%)Inox Clean 725 (0%)Lava 52 (0%)Matrix Gas 14 (-6.7%)Motilal Oswal 12.5 (-3.5%)MSEI 6.35 (1.6%)NCDEX 368 (-4.2%)NSE 1995 (0.5%)Onix Renewable 56 (-15.2%)OYO 24 (0%)OYO Assets 9.95 (-17.1%)Pharmeasy 6.25 (0%)Philips India 1250 (0%)Polymatech Electronics 56 (-9.7%)RRP S4E 158 (-6%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)Ticker Ltd 32 (0%)Zepto 42 (-14.3%)

15 Days Price Change

Galaxy Medicare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 22.31 Cr
Profile
Price Range 51  to  54 per share
Profile
Min Investment ₹54
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Our Company was originally incorporated in the name & style of “Galaxy Medicare Limited” on July 23, 1992, in Bhubaneswar, Odisha as a Public Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation bearing CIN: U24232OR1992PLC003113, issued by Registrar of Companies, Cuttack, Odisha. The Registered Office of the Company is situated at Plot No-2, Zone D, Mancheswar Industrial Estate, Bhubaneswar, Khorda, Odisha, -751010, India. The company commenced its operations in 1992 when our founder, Mr. Dillip Kumar Das, acquired a closed business unit from Odisha Industrial Infrastructure Development Corporation (IDCO) and Odisha State Financial Corporation under the investment promotion, facilitation and aftercare strategy of Industrial Promotion and Investment Corporation of Odisha (IPICOL) and revived the business unit to start manufacturing of Medical Devices such as Plaster of Paris Bandage (POP Bandage), Medical Tapes and Bandages, Other surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, etc. Our business operations have been led by our Promoter Mr. Dillip Kumar Das and assisted by his younger son, Mr. Subhasish Das and his Daughter-in-Law, Mrs. Kiran Das who have experience in the Medical Device, Plasters of Paris Bandages (POP Bandage) and Other Surgical Dressing Industry. Read More

Basic Info

Face Value 10 per share

Price 51  to  54 per share

P/E (x) 19.3

Sales( Cr.) 39

PAT( Cr.) 3

EPS 2.8

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Dillip Kumar Das Subhasish Das Kiran Das D.K. Das & Sons & HUF Industrial Designs & Services Pvt Ltd

Pre Issue Share Holding 99.57%

Post Issue Share Holding 72.43%

Listing Details:

Listing Price: 54

Listing Gain: 0%

Current Price: 19.3

Gain On Issue: 19.3 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Sep 10, 2025
Closing Date Sep 12, 2025
Allotment Sep 15, 2025
Refund Sep 16, 2025
Delivery of Shares Sep 16, 2025
Listing Date Sep 17, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 4000 216,000
Retail (Max) -- -- --
S-HNI (Min) 1 4000 216,000
S-HNI (Max) 4 16000 864,000
B-HNI (Min) 5 20000 1,080,000

Objective of the Issue

1. Funding Capital Expenditure requirement towards purchase of machinery for our existing manufacturing facility at Bhubaneshwar, Odisha2. Funding the working capital requirements3. General Corporate Purpose 4. To meet the Offer expenses

Issue

Category Nos Bid Bid (x)
QIB 0 80000 0x
NII 0 2474000 0x
Retail 0 4844000 0x
EMP 0 0 0x
Total 0 7398000 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Galaxy Medicare Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 30 31 36 39
Other Income 1 1 1 1
Total Income 31 32 37 40
Total Expenditure 27 29 31 34
Operating Profit 3 3 6 6
Interest 1 1 1 1
Depreciation 1 1 0 0
Exceptional Income / Expenses -1 1 0 0
Profit Before Tax 0 2 5 5
Provision for Tax 0 0 1 1
Profit After Tax -0 2 4 3
Adjustments 0 0 0 0
Profit After Adjustments -0 2 4 3
Adjusted Earnings Per Share -0.2 1.3 3.1 2.8

Galaxy Medicare Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 16 18 21 24
Minority's Interest 0 0 0 0
Borrowings 3 3 2 0
Other Non-Current Liabilities 0 0 0 0
Total Current Liabilities 11 12 9 7
Total Liabilities 30 32 32 31
Fixed Assets 15 14 14 14
Other Non-Current Assets 2 3 3 3
Total Current Assets 14 15 15 15
Total Assets 30 32 32 31

Galaxy Medicare Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0
Cash Flow from Operating Activities -1 4 3 4
Cash Flow from Investing Activities -1 -2 -1 0
Cash Flow from Financing Activities 1 -2 -2 -5
Net Cash Inflow / Outflow 0 -0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0

Galaxy Medicare Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0.18 1.32 3.12 2.84
CEPS(Rs) 0.65 2.26 3.53 3.26
DPS(Rs) 0.13 0.13 0.5 0.75
Book NAV/Share(Rs) 8.75 10.07 13.1 15.48
Core EBITDA Margin(%) 8.25 7.33 13.69 12.01
EBIT Margin(%) 3.25 9.47 15.67 13.45
Pre Tax Margin(%) 0.25 6.42 13.07 11.56
PAT Margin (%) -0.71 5.04 10.26 8.6
Cash Profit Margin (%) 2.58 8.61 11.59 9.87
ROA(%) -0.7 5.01 11.45 10.54
ROE(%) -2.05 14.08 26.98 19.88
ROCE(%) 4.78 14.27 25.32 22.61
Receivable days 87.43 94.75 82.64 66.2
Inventory Days 59.9 57.13 55.69 51.63
Payable days 74.3 82.18 60.29 24.93
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.42 0.38 0.54 0.41
EV/Core EBITDA(x) 3.75 3.8 3.42 2.77
Net Sales Growth(%) 0 4.44 15.85 8.44
EBIT Growth(%) 0 204.2 91.83 -6.93
PAT Growth(%) 0 837.05 135.93 -9.09
EPS Growth(%) 0 837.05 135.92 -9.09
Debt/Equity(x) 0.96 0.77 0.52 0.25
Current Ratio(x) 1.32 1.32 1.7 2.18
Quick Ratio(x) 0.86 0.9 1.02 1.44
Interest Cover(x) 1.08 3.11 6.03 7.13
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 8% 9% 0% 0%
Operating Profit CAGR 0% 26% 0% 0%
PAT CAGR -25% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 20% 20% 15% 15%
ROCE Average 23% 21% 17% 17%

Company Contact Information

Galaxy Medicare Ltd.

Pralaaju Naik

+91 9937000991

CS@galaxymed.co.in

Plot No. 2, Zone D, Mancheswar Industrial Estate Khurda

IPO Lead Manager(s)

Galaxy Medicare Ltd.

Affinity Global Capital Market Pvt Ltd.

Registrar Info

Galaxy Medicare Ltd.

Cameo Corporate Services Ltd

Subramanian Buildings No 1 , Club House Road,,Chennai

044-28460390/28460394

044-28460129

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp